6 days ago
1
Alexandros Michailidis
Olema Pharmaceutical's (NASDAQ:OLMA) announcement of a new clinical trial collaboration and supply agreement with Pfizer Inc. (PFE) in metastatic breast cancer may be a sign of a potential bidding war for Olema in the future, according to
English (US) ·